Your browser is no longer supported. Please, upgrade your browser.
XLV Health Care Select Sector SPDR ETF daily Stock Chart
Health Care Select Sector SPDR ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-0.05%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-2.54%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter-8.92%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y-13.69%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year-7.32%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range56.19 - 76.80 Perf YTD-10.63%
Dividend1.00 P/FCF- EPS past 5Y- ROI- 52W High-16.18% Beta-
Dividend %1.55% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low14.56% ATR1.57
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)40.37 Volatility2.03% 2.24%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.75 Prev Close63.52
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume13.77M Price64.37
Recom- SMA20-2.53% SMA50-6.54% SMA200-9.72% Volume10,289,171 Change1.34%
Feb-13-16 02:06PM  Alliance Datas Epsilon Segment Posted Stellar Results in 4Q15
02:05PM  AlereAbbott Labs Is a Large, Strategic Deal for Arbitrageurs
02:00PM  3 Healthcare Stocks That Gained Ground This Week at Motley Fool
11:21AM  How I'd Invest $500 Today at Motley Fool
Feb-12-16 08:16AM  Trade bets on bounce in health care
Feb-11-16 02:06PM  Analyzing the Future Estimates for Eli Lilly and Co.
02:05PM  MDTs Earnings Are Expected to Continue to Grow in Fiscal 3Q16
12:33PM  An ETF With An Equal Dose Of All Sectors
Feb-09-16 03:05PM  Cignas Diversification Strategy Boosts Its 4Q15 Earnings
01:08PM  What You Need to Know about the Abbott Labs Side of the Alere-Abbott Merger
01:07PM  The Alere-Abbott Labs Merger: Understanding the Alere Side
01:02PM  What Investors Can Expect from Healthcare Sector Companies
08:06AM  Eli Lilly and Co.s 4Q15: Profitability and Financial Guidance
Feb-08-16 06:33PM  Monday links: sickening stocks
12:07PM  Major Developments for Eli Lilly and Co. in 4Q15
12:07PM  Elancos 4Q15 Performance: Eli Lillys Animal Health Segment
10:53AM  How To Invest In An Aging World With The 'Live Long & Prosper' ETF
09:06AM  Solid Volume Growth Drove HCA Holdingss Revenue in 4Q15
09:05AM  Perrigos Shareholders Rejected Mylans Offer on Value Dilution
08:15AM  Trends driving deal flow
Feb-07-16 07:12PM  Fasten Your Seatbelts: More Craziness in the Week Ahead at TheStreet
Feb-05-16 01:19PM  A Checkup On A Big Healthcare ETF
07:21AM  Job growth slows, unemployment falls; oil tax; health insurance alliance
Feb-04-16 01:41PM  Aetna Posted Higher-than-Expected Earnings per Share in 4Q15
10:10AM  Rationale for the AlereAbbott Laboratories Merger
10:09AM  Abbott Labs Beefs Up Its Diagnostics Portfolio with Alere
Feb-01-16 09:04PM  Parsing the BaxaltaShire Material Adverse Effect Clause, Part 2
08:46PM  Analysts Expect MDTs Fiscal 3Q16 Revenues to be $6.9 Million
02:57PM  Strong Revenue for Abbott Point of Care Diagnostics Division
07:15AM  Can Boston Scientific Maintain Its Growth Momentum? at TheStreet
Jan-31-16 10:04PM  Parsing the BaxaltaShire Material Adverse Effect Clause, Part 1
08:07PM  Dan Deming's Health Care SPDR (ETF) Trade
Jan-30-16 08:05AM  Becton, Dickinson and Companys 1Q16 Earnings Estimates
08:05AM  Vertex Will Focus on Cystic Fibrosis Market in 2016
07:41AM  Will Obamacare Fail in 2016? Here are 3 Stocks Set to Benefit if it Does at Motley Fool
Jan-29-16 07:04PM  How Much Is Teva Spending on Research and Development?
04:13PM  Anthems Commercial and Specialty Enrollments Rose by 0.31 Million in 2015
03:51PM  Health care fundamentals still very strong: Manley
01:17PM  If history rhymes this indicator suggests stocks still have a long way to fall
01:00PM  Is this a sucker's bottom?
12:58PM  Top trades for the 2nd half: Earnings ahead
Jan-28-16 01:02PM  Analysts Expect Mylans Growth to Be at 29.7% for 4Q15
12:06PM  Vertexs Cystic Fibrosis Drugs and Their Controversial Prices
12:04PM  Insight into Tevas Over-the-Counter and Distribution Businesses
10:34AM  J&J Earnings Beat Fails to Cheer Healthcare ETFs
09:40AM  The Aetna Analysts: What Are They Recommending?
Jan-26-16 07:34AM  The BaxaltaShire merger: Basics of Shire Pharmaceuticals
07:26AM  AbbVie in 4Q15: Analysts Project Strong Revenue Growth
Jan-25-16 02:49PM  Becton, Dickinson and Companys 1Q16 Revenues Expected to Grow
Jan-22-16 03:06PM  Abbott Laboratories 4Q15 EPS Expected to Rise Significantly
03:05PM  Will Professional Arbitrageurs Set up the BaxaltaShire Spread?
02:20PM  Sculley's game changers
01:13PM  Athenahealth CEO on innovation in health care
05:58AM  How Johnson & Johnson Can Restore Your Portfolio's Health at TheStreet
Jan-20-16 02:37PM  Israeli app uses smartphone camera to make medical diagnoses
10:27AM  Sanofi Rose 3.5%, Disclosed a Deal Worth up to 1.2 Billion Euros
09:57AM  Abbott Laboratories 4Q15 Revenues Expected to Fall
Jan-19-16 02:44PM  Stocks Slide as Crude Oil Struggles to Hold $28 at TheStreet
12:06PM  The BaxaltaShire Deals Risk-to-Reward Ratio Is around 1:1
12:06PM  Could the Baxalta and Shire Merger Get Competitive?
07:24AM  The BaxaltaShire Merger: Baxalta, a Biopharmaceutical Company
Jan-18-16 10:30AM  Are Unfavorable Ratios Impacting Future Buying Power?
Jan-17-16 09:06AM  Whats the Path to Approval for the BaxaltaShire Transaction?
09:00AM  The Best Healthcare ETF of the Week at Motley Fool
Jan-15-16 09:35AM  2016 is the year to be very cautious on U.S. stocks: Money Manager
09:06AM  Growth and Synergies Drive the BaxaltaShire Merger
09:06AM  Basics and Conditions of the BaxaltaShire Merger
08:37AM  The Best Healthcare Stocks for 2016 at Motley Fool
Jan-14-16 07:09AM  Shire Seals the Deal with Baxalta after a Long Negotiation
Jan-13-16 01:07PM  Strykers 4Q15 Revenues Expected to Witness Growth
01:05PM  Is The Time Ripe for Ex-Health Care S&P 500 ETF?
07:03AM  Sizing up the economy: Pro
Jan-12-16 01:02PM  Biotech On the Edge? Try Better-Performing Health Care ETFs
Jan-11-16 12:13PM  The pharma trade
08:07AM  Thermo Fishers Life Sciences Solutions: Analysts Estimates
08:06AM  What to watch at J.P. Morgan Health Care Conference
Jan-08-16 12:31PM  Rob Sechan: Don't panic, here's your ideal portfolio
05:53AM  Good jobs report could restore market confidence: Pro
Jan-07-16 02:47PM  For U.S. stocks, its a China in a bull shop at MarketWatch
09:36AM  The Top 5 Health Care ETFs for 2016 (XLV, VHT) at Investopedia
Jan-06-16 06:05PM  How Did FEZs Pharmaceutical Industry Perform?
Jan-05-16 12:49PM  Tuesday links: genuine returns
Jan-02-16 08:29PM  The Two Best Sector SPDR ETFs For January
Dec-31-15 01:58PM  Healthcare Stock Mallinckrodt Emerged as One of the Top Stocks
11:52AM  Thursday links: obvious mistakes
07:39AM  The Worst Obamacare Stocks of 2015 at Motley Fool
Dec-30-15 01:20PM  Vertex Up 3.2% as Healthcare Sector Continued to Lure Investors
10:40AM  Santelli Exchange: Obamacare overhaul
09:46AM  Bullish A/D Line Signals Upside Breakout at Forbes
Dec-29-15 09:51AM  What Market Pros Will Be Watching in 2016
08:06AM  Tenet Rose 7.6% as Obamacare Enrollment Increased
Dec-28-15 02:06PM  Celgene Soared after Settling Patent Litigation
12:38PM  Health care watch list
09:12AM  Analysts Project Weak Revenue Growth for Amgen
07:41AM  XLV Was Trading Higher after Paying Dividends
07:16AM  Cost of failure high in biotech space: Pro
Dec-26-15 12:16PM  XLV: Health Care Select Sector SPDR ETF at Investopedia
Dec-24-15 09:12AM  Healthy Balance Sheets May Protect Your Returns in 2016
Dec-23-15 08:05PM  Eli Lilly Rose on FDAs Approval of Basaglar
05:06PM  Waters Led XLVs Electronic Subgroup
The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.